Idiopathic Pulmonary Fibrosis: Is All-Cause Mortality a Practical and Realistic End-Point for Clinical Trials?
Thorax - United Kingdom
doi 10.1136/thoraxjnl-2012-203114
Full Text
Open PDFAbstract
Available in full text
Date
January 23, 2013
Authors
Publisher
BMJ